Main > ONCOLOGY (**) > Multiple Myeloma R/R *** > Treatment > CN. C. CAR-T Therapy BCMA Directed

---

CN. C. CAR-T Therapy BCMA Directed's subsections
Company
Patent>Assignee; Claims; No.; Etc.
Patent>UpDate: 2022. 03.01
Status: Phase 1
Web-Site

CN. C. CAR-T Therapy BCMA Directed's products
This section has no products